Articles On Medlab Clinical (ASX:MDC)

The NanoCBD will be the first of two CBD programs to be launched by Medlab into the UK market. Australian biotech Medlab Clinical (ASX:MDC) is ready to export its medicinal cannabis program, the NanoCBD, to the UK market. The company has be...

Medlab’s focus on improving patient outcomes is leading to a homegrown revolution in the way drug medications are effectively delivered to patients. Australian Biotech Medlab Clinical (ASX:MDC) is positioning itself for a milestone year aft...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The ACIC says weed consumption increased in cities and regions ROO receives USA design patent approval for its Heat Exchange Probe EMD has launched its second ultra-pure CBD capsule, the EMD-RX7   The latest Australian Criminal Intelligen...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIZ)) - Air New Zealand ((ART)) - Airtasker ((APX)) - Appen ((ALX)) - Atlas Arteria ((AIA)) - Auckland International Airport ((AMI)) - Aurelia Metals ((ACL)) - Australia...

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Highlights Australia reported 31,064 new COVID-19 cases in the last 24 hours, taking the total number of cases to 2,436,656. Fully vaccinated tourists and visa holders can travel to Australia from 21 February. Eligible Australian kids...

Medlab Clinical (ASX:MDC) says it has received 'Favourable Opinion' status from the UK Research Ethics Committee for the forthcoming NanaBis Phase 3 trial.

In December France banned the sale of hemp flower and leaf loaded with CBD, but the Conseil d’Etat provisionally overruled the decision on Wednesday – pending further examination of the order. Basically, the French court said that flowers...

Medlab Clinical (MDC) reports positive net operating cashflows for the December quarter of $645,000 Revenue at the half-year was $5.6 million, representing a 33 per cent growth from the previous corresponding period The company spent $851,...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

Sean Hall of Medlab Clinical speaks at the Switzer Small and Micro Cap Investor Strategy Day 2021.

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

The Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product sales estimated at $230 million. And medical cannabis prescriptions are at an all-time high. The TGA said 13,666 Australian patients were app...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Uber is expanding its horizons, with plans to allow users to order cannabis on its Uber Eats app. Next week the app will list cannabis retailer Tokyo Smoke on its marketplace and customers will be able to place orders on the app – but they...

The ASX 200 Health Index (XHJ) is down by 1.0% at the time of writing, compared to the broader index which is down by 0.1%. Medical diagnostics company, Universal Biosensors (ASX:UBI), has entered into a collaboration agreement with Mayo Cl...

Instead of a chocolate advent calendar this year, Californians can get their hands on a cannabis calendar with edibles, prerolls, grams of flower and four days of cannabis accessories. “We’ve seen the success of unique advent calendars in o...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

The US Patent & Trademark Office (USPTO) grants patent protection for Medlab Clinical’s (MDC) NanoCelle technology in the United States NanoCelle is Medlab’s drug delivery nanotechnology that aims to overcome the current obstacles surr...

The ASX 200 Health Index (XHJ) is up by 0.40% at the time of writing, compared to the broader index which is higher by 0.30%. Neurology specialist, Invex Therapeutics (ASX:IXC), soared 13% after announcing that it’s about to launch a Phase...

Wall Street at fresh record highs as Fed begins tapering US stocks closed their fourth consecutive days of new record highs, the longest stretch since October of 2017. It came as the US Fed announced the beginning of its Treasury tapering p...

Actor Jim Belushi has partnered with – you guessed it – Dan Aykroyd on a tour through Oklahoma’s cannabis industry ahead of a Blues Brothers performance. “We believe that cannabis is one of the great, great medicines that can lead to a path...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Power says...

The ASX 200 Health Index (XHJ) is up by 1.2% at the time of writing, compared to the broader index which is higher by 1%. Truscreen Group (ASX:TRU) was the best health stock performer, up by 38% after reporting key milestones including the...

Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow...

The ASX finished September on a solid note but not enough to avoid the worst month since March 2020. The ASX 200 closed at 7,332 points which was 1.88% higher than yesterday but nearly 3% lower than it started the month at. However it is up...

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Today, Wednesday the 1st of September, we are happy to buy Bluebet Holdings Ltd (ASX:BBT), Regis Resources (ASX:RRL), Sandfire Resources (ASX:SFR), Motorcycle Hldg (ASX:MTO), Regis Healthcare Ltd (ASX:REG), Panoramic Resources (ASX:PAN) and...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((BBT)) - BlueBet Holdings ((BUB)) - Bubs Australia ((BWX)) - BWX ((CRW)) - Cashrewards ((CMW)) - Cromwell Property ((DCN)) - Dacian Gold ((EOS)) - Electro Optic Systems (...

Virginia is the latest US state to legalise marijuana and they’re celebrating with the first annual CannaFest VA cannabis trade show on September 19. The event will feature a concert, and a custom car and motorcycle exhibition but no, you c...

Local markets continued their strong form on Wednesday as the ASX rose for the third straight session. Reporting season threw up some big-name winners as markets responded to the latest round of full-year results. While the ASX 200 edged hi...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Massachusetts based cannabis operator MariMed has just announced a joint collaboration with the legendary Boston ice cream brand Emack & Bolio’s® to create a line-up of cannabis-infused vegan and dairy ice cream. The ice cream will cont...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business mana...

Australian shares have extended gains for the second day in a row, rising by 0.91% despite more COVID cases across states. All 11 sectors were in the green, except for Healthcare. Mining and Energy led the gains, rising by 2% each, buoyed b...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

Summary Australian Ethics grants approval for Medlab’s NanaBis™ PIII Australian Sites Live Verdure launches first TGA registered product, shares zoom up Fertoz at over 6-1/2-year high on new partnerships for carbon unit  The S&am...

Summary The S&P/ASX200 gained as much as 1.1% to 7,353 on Monday. The market witnessed a surge in buying, led by miners, banks, and energy stocks. Seven of 11 sectors were trading in green, led by materials with 2.25% gain. NRW H...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Healthcare fi...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...